The impact of highest doses of ACEi/ARB therapy on mortality of patients suffering from heart failure with reduced ejection fraction: a long-term follow-up, propensity-matched cohort study
31 August 2019 (00:00 - 00:00)
Organised by:
About the speaker
Gottsegen National Cardiovascular Center, Budapest (Hungary)
8 More presentations in this session
Professor D. Logeart (Paris, FR)
Doctor S. Scalvini (Lumezzane, IT)
Doctor N. Pavo (Vienna, AT)
Access the full session
The Event
ESC Congress 2019
31 August - 4 September 2019
